<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02014597</url>
  </required_header>
  <id_info>
    <org_study_id>H-30109</org_study_id>
    <nct_id>NCT02014597</nct_id>
  </id_info>
  <brief_title>Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma</brief_title>
  <acronym>HOCD</acronym>
  <official_title>Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benjamin Frankfort, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if an optokinetic contrast detection device is&#xD;
      sufficient to measure contrast sensitivity and to distinguish between patients with and&#xD;
      without glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protocol is divided into two studies that will have two separate consent forms (Study 1&#xD;
      and Study 2).&#xD;
&#xD;
      Study 1 involves the optimization of the device parameters. Study 1 will test adult subjects&#xD;
      with no history of ocular disease (Study 1A) to assess the limits of human contrast&#xD;
      sensitivity and subjects with definite glaucoma (Study 1B) by gathering preliminary data for&#xD;
      comparison. These two pilot sub-studies intend to provide rapid data in regard to the device&#xD;
      testing results to support the study hypothesis. This strategy will help rule out false&#xD;
      negatives and false positives so that any adjustments can be made prior to the start of Study&#xD;
      2 for longitudinal data collection. Study 2 involves determination of baseline population&#xD;
      parameters for an older population more likely to be age-matched with patients with glaucoma,&#xD;
      as well as performance of patients with various levels of glaucoma severity.&#xD;
&#xD;
      Enrollment of participants in Study 1B will begin after the first 5 participants have been&#xD;
      enrolled and tested in Study 1A. Study 2 will begin after Study 1A and B are complete.&#xD;
&#xD;
      Study 1: No more than 20 adult subjects with no history of ocular disease and no more than 20&#xD;
      adults subjects with definite glaucoma will be recruited to assist with optimization of&#xD;
      device parameters.&#xD;
&#xD;
      Study 1A: The individuals will not be patients of the co-investigators but rather volunteers&#xD;
      who are recruited by word of mouth (co-employees, residents, research staff, etc.) and are&#xD;
      willing to volunteer their time to assist in the development of the project. Volunteers can&#xD;
      be of any age &gt;18, male or female, and must be of self-reported excellent ocular health. Best&#xD;
      spectacle corrected visual acuity of 20/40 or better is required (verified by Snellen acuity&#xD;
      testing on the day of participation) and the participant must have no reported history of&#xD;
      glaucoma, retinal disease, amblyopia, ocular trauma, or ocular surgery of any kind with the&#xD;
      exception of refractive surgery (LASIK, PRK, or equivalent).&#xD;
&#xD;
      Study 1B: These individuals will be recruited from the Alkek Eye Center patient population&#xD;
      with confirmed diagnosis of glaucoma and of any age &gt; 18.&#xD;
&#xD;
      Study 2: Potential subjects will be recruited from the Department of Ophthalmology at Baylor&#xD;
      College of Medicine and their families. We will recruit 100 patients for this study in the&#xD;
      following distribution:&#xD;
&#xD;
        1. 20 normal controls age 50 or older&#xD;
&#xD;
        2. 20 patients age 50 or older with ocular hypertension&#xD;
&#xD;
        3. 20 patients age 50 or older who are glaucoma suspects&#xD;
&#xD;
        4. 20 patients age 50 or older with early to moderate glaucoma&#xD;
&#xD;
        5. 20 patients age 50 or older with moderate to advanced glaucoma&#xD;
&#xD;
      Study 1: Subjects participating in this portion of the study will attend one single visit: 1)&#xD;
      Informed consent will be obtained and inclusion/exclusion criteria will be confirmed.&#xD;
      Demographic information, ocular history, refraction, and visual acuity information will be&#xD;
      collected for all patients. Additional clinical data will also be collected for Study 1B&#xD;
      participants only. Information to be collected will include name, date of birth, ethnicity,&#xD;
      gender, ocular history (surgery, etc), type of glaucoma (Study 1B), current visual acuity,&#xD;
      refraction, central corneal thickness (Study 1B), intraocular pressure (Study 1B), recent&#xD;
      slit lamp exam including lens status (Study 1B), recent dilated exam including optic nerve&#xD;
      appearance (Study 1B), and recent automated perimetry results (Humphrey visual field, Study&#xD;
      1B) 2) Snellen visual acuity will be measured while wearing current spectacle correction to&#xD;
      ensure acuity of 20/40 or better. The current spectacle correction (refraction) and acuity&#xD;
      will be recorded. 3) OKR (optokinetic reflex)-based contrast testing will be performed with&#xD;
      the OCD - optokinetic contrast device (the device in study with this protocol). Subjects will&#xD;
      be shown a brief demonstration of the OCD under red light (to begin dark adaptation) to&#xD;
      familiarize themselves with the device and the expected testing strategy. 4) Subjects will&#xD;
      then be dark adapted for 20-30 minutes. During this time they will be sitting in a darkened&#xD;
      room. If the room is not dark enough a loose blindfold may be used. Music options will be&#xD;
      available to help pass the time and ease potential discomfort. 5) After 20-30 minutes the&#xD;
      blindfold will be removed (if used) and patient will have monocular dark-adapted (scotopic)&#xD;
      testing done with the OCD, left eye followed by right eye. The non-tested eye may be covered&#xD;
      during testing. After scotopic testing, the light of the OCD will be increased and&#xD;
      light-adapted (photopic) testing will be performed in the same manner. 6) Debriefing.&#xD;
      Subjective assessments of the testing modality and dark adaptation process will be collected.&#xD;
&#xD;
      *************************&#xD;
&#xD;
      Study 2: Study subjects participating in this portion of the study will require two study&#xD;
      visits.&#xD;
&#xD;
      Potential participants will be approached by the PI to ask if they are willing to participate&#xD;
      in this study. If the subject agrees to participate, during their next scheduled clinic&#xD;
      visit, the PI will also do a slit lamp examination including lens status using the AREDS 2008&#xD;
      Clinical Lens Opacity Grading Standards in addition to their standard of care clinic eye&#xD;
      visit. The slit lamp examination including lens status using the AREDS 2008 Clinical Lens&#xD;
      Opacity Grading Standards is the only research related activity in this clinic visit.&#xD;
      Potential participants who are the &quot;normals&quot; for Study 2 will be recruited from one of the&#xD;
      co-investigator's clinic who is their treating physician. If interested, their physician&#xD;
      (co-investigator) will contact the research coordinator to meet or call the patient and&#xD;
      explain the study. If he/she agrees to participate, the PI will do a slit lamp examination at&#xD;
      their next scheduled visit in the same manner as the other Study 2 participants, except the&#xD;
      central corneal thickness will also be determined by ultrasonic pachymetry (standard testing&#xD;
      for patients with glaucoma but not normal controls). Data from these clinic visits will be&#xD;
      used as baseline information for the study. The baseline clinical and demographic data to be&#xD;
      collected in the study will be: 1. Date of Birth 2. Ethnicity 3. Gender 4. Ocular History&#xD;
      (surgery, etc) 5. Type of Glaucoma 6. Current visual acuity 7. Refraction 8. Central corneal&#xD;
      thickness 9. Intraocular Pressure 10. Slit lamp examination including lens status by methods&#xD;
      above 11. Dilated examination including optic nerve appearance 12. Recent automated perimetry&#xD;
      results (Humphrey visual field)&#xD;
&#xD;
      Research Study Visit 1 (within 2 months of clinic visit from which clinical data is&#xD;
      obtained):&#xD;
&#xD;
        1. Humphrey standard automated perimetry (visual field testing). This is a form of static&#xD;
           perimetry used to assess retinal function and sensitivity. It is a commonly used&#xD;
           photopic testing modality for the diagnosis and status of glaucoma and used frequently&#xD;
           throughout ophthalmology and many ophthalmologic clinical studies. We hypothesize that&#xD;
           there will be similarities in performance between Humphrey automated perimetry and OKR&#xD;
           testing which will help validate our testing strategy. For patients with glaucoma, for&#xD;
           whom visual field testing is frequently performed, this test will not be performed if a&#xD;
           high-quality visual field test has been obtained within the last 6 months. For such&#xD;
           patients, the visual field test from the clinical record will be used in the study.&#xD;
&#xD;
        2. OKR-based contrast testing will be performed with the OCD - optokinetic contrast device&#xD;
           (the device in study with this protocol). Subjects will be shown a brief demonstration&#xD;
           of the OCD under infrared light (to begin dark adaptation) to familiarize themselves&#xD;
           with the device and the expected testing strategy.&#xD;
&#xD;
        3. Subjects will then be dark adapted for 20-30 minutes. During this time they may be&#xD;
           blindfolded (depending on darkness of the room) and sitting in a dark room. Music&#xD;
           options will be available to help pass the time and ease potential discomfort.&#xD;
&#xD;
        4. After 20-30 minutes, the blindfold will be removed (if used) and patient will have&#xD;
           monocular dark-adapted (scotopic) testing done with the OCD, left eye followed by right&#xD;
           eye. The non-tested eye may be covered during testing.&#xD;
&#xD;
        5. After scotopic testing, the light of the OCD will be increased and light-adapted&#xD;
           (photopic) testing will be performed in the same manner.&#xD;
&#xD;
      This visit should take approximately 90 minutes to complete.&#xD;
&#xD;
      Second Research Visit (approximately 1 month after the first research visit):&#xD;
&#xD;
        1. Pelli-Robson Contrast Sensitivity Testing. This is a form of stationary central vision&#xD;
           contrast sensitivity that is a commonly used testing modality for photopic contrast in&#xD;
           many ophthalmologic clinical studies. We hypothesize that there will be similarities in&#xD;
           contrast performance between Pelli-Robson and OKR testing which will help validate our&#xD;
           testing strategy.&#xD;
&#xD;
        2. OKR-based contrast testing. This will be performed as in the second visit described&#xD;
           above except that the testing order will be the right eye first, followed by the left&#xD;
           eye.&#xD;
&#xD;
        3. Debriefing. Subjective assessments of the testing modality and dark adaptation process&#xD;
           will be collected.&#xD;
&#xD;
      This visit should take approximately 90 minutes to complete.&#xD;
&#xD;
      For those participating in Study 2, participants will be asked if they will allow the study&#xD;
      staff to review their medical records to track clinical outcomes for 5 years. Participants&#xD;
      will be asked to allow review of their medical records related to their developing or not&#xD;
      developing glaucoma or other eye conditions to collect longitudinal data. This is an optional&#xD;
      portion of the test for which they can opt out.&#xD;
&#xD;
      The following information will be re-reviewed: 1. Date of Birth 2. Ethnicity 3. Gender 4.&#xD;
      Ocular History (surgery, etc) 5. Type of Glaucoma 6. Visual acuity 7. Refraction 8. Central&#xD;
      corneal thickness 9. Intraocular Pressure 10. Slit lamp examinations including lens status&#xD;
      11. Dilated examinations including optic nerve appearance 12. Automated perimetry results&#xD;
      (Humphrey visual field)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    funding lapse; enrollment difficulty&#xD;
  </why_stopped>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">August 22, 2017</completion_date>
  <primary_completion_date type="Actual">August 22, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated Contrast Sensitivity in Log Units (logCS)</measure>
    <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured on the day of enrollment and 1 month later - not started (early Termination).</time_frame>
    <description>The HOCD willl be used to estimate the logCS of both eyes in both dark (scotopic) and light (photopic) conditions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare Log Contrast Sensitivity in Subjects With and Without Glaucoma</measure>
    <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured on the day of enrollment and 1 month later - not started (early Termination).</time_frame>
    <description>Measure differences in logCS between subjects with and without glaucoma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare Log Contrast Sensitivity Measured With the HOCD to White on White Sensitivity Via Automated Perimetry</measure>
    <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured on the day of enrollment - not started (early Termination).</time_frame>
    <description>Measure contrast sensitivity with the HOCD (logCS) and then compare to automated perimetry results (Decibels). For subjects with glaucoma this will be performed as part of both Study 1 and Study 2. For normal control subjects, this will only be performed as part of Study 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare Contrast Sensitivity Measured With the HOCD to Contrast Sensitivity Testing Via Pelli Robson Contrast Sensitivity Chart Testing.</measure>
    <time_frame>Study 2: Measured 1 month after the day of enrollment - not started (early Termination).</time_frame>
    <description>Compare contrast sensitivity measured with the HOCD (logCS) to contrast sensitivity testing via Pelli Robson Contrast Sensitivity Chart testing. Study 2 only.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Tolerance of Testing as Measured Via Questionnaire</measure>
    <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured 1 month after the day of enrollment - not started (early Termination).</time_frame>
    <description>Subjects will be asked to relate their experiences with the test to determine how well it is tolerated. Subjects will be asked to report their agreement with five statements.&#xD;
This is reported on a custom scale: 1 = Do Not Agree; 2 = Partially Agree; 3 = Mostly Agree; 4 = Fully Agree.&#xD;
Higher scores represent more complete agreement with the statement.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Normal - No glaucoma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HOCD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glaucoma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HOCD</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HOCD</intervention_name>
    <description>feasibility of HOCD and comparison of HOCD results between subjects with and without glaucoma</description>
    <arm_group_label>Glaucoma</arm_group_label>
    <arm_group_label>Normal - No glaucoma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Normal controls for Study 1&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. age 18 or older&#xD;
&#xD;
          3. Corrected visual acuity 20/40 or better in both eyes.&#xD;
&#xD;
        Normal Controls for Study 2&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. age 50 or older&#xD;
&#xD;
          3. IOP (intraocular pressure) 21 or less in both eyes&#xD;
&#xD;
          4. Corrected visual acuity 20/40 or better in both eyes.&#xD;
&#xD;
        Subjects with glaucoma/ocular hypertension&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. Age 50 or older&#xD;
&#xD;
          3. Defined as IOP&gt; 21 without medication on two or more clinic visits in one or both eyes&#xD;
&#xD;
          4. Corrected visual acuity 20/40 or better&#xD;
&#xD;
          5. Normal optic nerves&#xD;
&#xD;
          6. Normal automated perimetry in both eyes&#xD;
&#xD;
        Subjects who are glaucoma/glaucoma suspects&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. Age 50 or over&#xD;
&#xD;
          3. Increased optic nerve cupping in one or both eyes regardless of IOP&#xD;
&#xD;
          4. Corrected visual acuity 20/40 or better&#xD;
&#xD;
          5. Normal automated perimetry in both eyes&#xD;
&#xD;
        Subjects with early to moderate glaucoma&#xD;
&#xD;
          1. Male or female&#xD;
&#xD;
          2. Age 50 or over&#xD;
&#xD;
          3. Increased optic nerve cupping regardless of IOP in one or both eyes&#xD;
&#xD;
          4. Corrected visual acuity 20/40 or better in both eyes&#xD;
&#xD;
          5. Early to moderate perimetric changes defined as a mean deviation (MD) no less than&#xD;
             -7.5 and a pattern standard deviation (PSD) no greater than +7.5 in the worse eye.&#xD;
&#xD;
        Subjects with moderate to advanced glaucoma&#xD;
&#xD;
          1. Male of Female&#xD;
&#xD;
          2. Age 50 or older&#xD;
&#xD;
          3. Increased optic nerve cupping regardless of IOP in one or both eyes&#xD;
&#xD;
          4. Grossly abnormal automated perimetry (MD less than -7.5 or PSD greater than +7.5 in&#xD;
             the worse eye)&#xD;
&#xD;
          5. Best-corrected visual acuity of 20/40 or better in both eyes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Normal Controls (both studies):&#xD;
&#xD;
               1. glaucoma or glaucoma suspicion in either eye&#xD;
&#xD;
               2. IOP &gt; 21 in either eye&#xD;
&#xD;
               3. History of use of IOP-reducing drops in either eye except temporarily following&#xD;
                  cataract extraction&#xD;
&#xD;
               4. History of any ocular surgery except cataract extraction or refractive surgery&#xD;
                  (LASIK, PRK, or equivalent) in either eye&#xD;
&#xD;
               5. Retinal disease in either eye&#xD;
&#xD;
               6. Abnormal measured automated perimetry in either eye&#xD;
&#xD;
               7. Abnormal measured contrast sensitivity in either eye&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin J. Frankfort, M.D. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alkek Eye Center, Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 26, 2013</study_first_submitted>
  <study_first_submitted_qc>December 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2013</study_first_posted>
  <results_first_submitted>October 5, 2020</results_first_submitted>
  <results_first_submitted_qc>October 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 18, 2020</results_first_posted>
  <last_update_submitted>October 27, 2020</last_update_submitted>
  <last_update_submitted_qc>October 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Benjamin Frankfort, MD, PhD</investigator_full_name>
    <investigator_title>Associate Professor, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 11, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT02014597/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Normal subjects were recruited by word of mouth (medical clinic staff, employees, friends, relatives); Glaucoma subjects were recruited from a glaucoma specific clinic.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Normal</title>
          <description>Normal subjects without glaucoma</description>
        </group>
        <group group_id="P2">
          <title>Glaucoma</title>
          <description>Subjects with glaucoma</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unable to record log contrast sensitivity</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normal</title>
          <description>Normal subjects without glaucoma</description>
        </group>
        <group group_id="B2">
          <title>Glaucoma</title>
          <description>Subjects with glaucoma</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Best Corrected Vision = 20/40 or better</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Estimated Contrast Sensitivity in Log Units (logCS)</title>
        <description>The HOCD willl be used to estimate the logCS of both eyes in both dark (scotopic) and light (photopic) conditions.</description>
        <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured on the day of enrollment and 1 month later - not started (early Termination).</time_frame>
        <population>Scotopic and photopic logCS for both eyes (right and left)</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>Normal subjects without glaucoma</description>
          </group>
          <group group_id="O2">
            <title>Glaucoma</title>
            <description>Subjects with glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Contrast Sensitivity in Log Units (logCS)</title>
          <description>The HOCD willl be used to estimate the logCS of both eyes in both dark (scotopic) and light (photopic) conditions.</description>
          <population>Scotopic and photopic logCS for both eyes (right and left)</population>
          <units>logCS</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Scotopic - right eyes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.26" lower_limit="1.19" upper_limit="1.58"/>
                    <measurement group_id="O2" value="1.50" lower_limit="1.43" upper_limit="1.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Scotopic - left eyes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.45" lower_limit="1.32" upper_limit="1.64"/>
                    <measurement group_id="O2" value="1.70" lower_limit="1.35" upper_limit="1.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic - right eyes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.264" lower_limit="-0.428" upper_limit="1.57"/>
                    <measurement group_id="O2" value="-0.188" lower_limit="-0.44" upper_limit="0.0417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic - left eyes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" lower_limit="-0.0663" upper_limit="1.62"/>
                    <measurement group_id="O2" value="-0.0933" lower_limit="-0.502" upper_limit="0.857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Compare Log Contrast Sensitivity in Subjects With and Without Glaucoma</title>
        <description>Measure differences in logCS between subjects with and without glaucoma.</description>
        <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured on the day of enrollment and 1 month later - not started (early Termination).</time_frame>
        <population>Scotopic and photopic logCS (right and left eyes pooled together)</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>Normal subjects without glaucoma</description>
          </group>
          <group group_id="O2">
            <title>Glaucoma</title>
            <description>Subjects with glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Compare Log Contrast Sensitivity in Subjects With and Without Glaucoma</title>
          <description>Measure differences in logCS between subjects with and without glaucoma.</description>
          <population>Scotopic and photopic logCS (right and left eyes pooled together)</population>
          <units>logCS</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Scotopic - all eyes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.42" lower_limit="1.22" upper_limit="1.58"/>
                    <measurement group_id="O2" value="1.52" lower_limit="1.36" upper_limit="1.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Photopic - all eyes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" lower_limit="-0.322" upper_limit="1.59"/>
                    <measurement group_id="O2" value="-0.188" lower_limit="-0.462" upper_limit="0.536"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0583</p_value>
            <p_value_desc>Scotopic logCS</p_value_desc>
            <method>Kruskal-Wallis</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.1762</p_value>
            <p_value_desc>Photopic logCS</p_value_desc>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Compare Log Contrast Sensitivity Measured With the HOCD to White on White Sensitivity Via Automated Perimetry</title>
        <description>Measure contrast sensitivity with the HOCD (logCS) and then compare to automated perimetry results (Decibels). For subjects with glaucoma this will be performed as part of both Study 1 and Study 2. For normal control subjects, this will only be performed as part of Study 2.</description>
        <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured on the day of enrollment - not started (early Termination).</time_frame>
        <population>Only subjects with glaucoma had automated perimetry for comparison in Study 1. Eyes were pooled for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>Normal subjects without glaucoma</description>
          </group>
          <group group_id="O2">
            <title>Glaucoma</title>
            <description>Subjects with glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Compare Log Contrast Sensitivity Measured With the HOCD to White on White Sensitivity Via Automated Perimetry</title>
          <description>Measure contrast sensitivity with the HOCD (logCS) and then compare to automated perimetry results (Decibels). For subjects with glaucoma this will be performed as part of both Study 1 and Study 2. For normal control subjects, this will only be performed as part of Study 2.</description>
          <population>Only subjects with glaucoma had automated perimetry for comparison in Study 1. Eyes were pooled for analysis.</population>
          <units>Decibels</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="-2.82" spread="3.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PSD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="4.34" spread="3.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between logCS and MD.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.183</p_value>
            <p_value_desc>Scotopic</p_value_desc>
            <method>Pearson correlation</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between logCS and MD.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.771</p_value>
            <p_value_desc>Photopic</p_value_desc>
            <method>Pearson correlation</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between logCS and PSD.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.492</p_value>
            <p_value_desc>Scotopic</p_value_desc>
            <method>Pearson correlation</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Correlation between logCS and PSD.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.830</p_value>
            <p_value_desc>Photopic</p_value_desc>
            <method>Pearson correlation</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Compare Contrast Sensitivity Measured With the HOCD to Contrast Sensitivity Testing Via Pelli Robson Contrast Sensitivity Chart Testing.</title>
        <description>Compare contrast sensitivity measured with the HOCD (logCS) to contrast sensitivity testing via Pelli Robson Contrast Sensitivity Chart testing. Study 2 only.</description>
        <time_frame>Study 2: Measured 1 month after the day of enrollment - not started (early Termination).</time_frame>
        <population>Study 2 never performed due to early Termination</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>Normal subjects without glaucoma</description>
          </group>
          <group group_id="O2">
            <title>Glaucoma</title>
            <description>Subjects with glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Compare Contrast Sensitivity Measured With the HOCD to Contrast Sensitivity Testing Via Pelli Robson Contrast Sensitivity Chart Testing.</title>
          <description>Compare contrast sensitivity measured with the HOCD (logCS) to contrast sensitivity testing via Pelli Robson Contrast Sensitivity Chart testing. Study 2 only.</description>
          <population>Study 2 never performed due to early Termination</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Tolerance of Testing as Measured Via Questionnaire</title>
        <description>Subjects will be asked to relate their experiences with the test to determine how well it is tolerated. Subjects will be asked to report their agreement with five statements.&#xD;
This is reported on a custom scale: 1 = Do Not Agree; 2 = Partially Agree; 3 = Mostly Agree; 4 = Fully Agree.&#xD;
Higher scores represent more complete agreement with the statement.</description>
        <time_frame>Study 1: Measured on the day of enrollment - reported only for those enrolled (early Termination). Study 2: Measured 1 month after the day of enrollment - not started (early Termination).</time_frame>
        <population>Only the subjects for whom testing was completed are described.</population>
        <group_list>
          <group group_id="O1">
            <title>Normal</title>
            <description>Normal subjects without glaucoma</description>
          </group>
          <group group_id="O2">
            <title>Glaucoma</title>
            <description>Subjects with glaucoma</description>
          </group>
        </group_list>
        <measure>
          <title>Tolerance of Testing as Measured Via Questionnaire</title>
          <description>Subjects will be asked to relate their experiences with the test to determine how well it is tolerated. Subjects will be asked to report their agreement with five statements.&#xD;
This is reported on a custom scale: 1 = Do Not Agree; 2 = Partially Agree; 3 = Mostly Agree; 4 = Fully Agree.&#xD;
Higher scores represent more complete agreement with the statement.</description>
          <population>Only the subjects for whom testing was completed are described.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>I understood the test instructions.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="4" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I was physically comfortable during the test.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O2" value="3.6" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>The length of the test was appropriate.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="3.6" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I had problems with the time spent in the dark.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>I would recommend this test if likely to diagnose glaucoma sooner.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="4" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Day of study enrollment</time_frame>
      <desc>Adverse events were monitored on the day of study enrollment. There were no return study dates.</desc>
      <group_list>
        <group group_id="E1">
          <title>Normal</title>
          <description>Normal subjects without glaucoma</description>
        </group>
        <group group_id="E2">
          <title>Glaucoma</title>
          <description>Subjects with glaucoma</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Benjamin Frankfort</name_or_title>
      <organization>Baylor College of Medicine</organization>
      <phone>713-798-3453</phone>
      <email>benjamin.frankfort@bcm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

